You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 107 No. 4, April 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Transforming growth factor beta. A biologic chorioretinal glue

W. E. Smiddy, B. M. Glaser, W. R. Green, T. B. Connor Jr, A. B. Roberts, R. Lucas and M. B. Sporn
Bascom Palmer Eye Institute, Miami.

Transforming growth factor beta (TGF-beta) stimulates fibrosis. We studied its possible role as a bioactive substance for inducing localized chorioretinal wound healing along the edge of a retinal tear. The TGF-beta was applied to induced retinal tears that were examined histopathologically. One day after surgery, neither control nor TGF-beta-treated eyes developed chorioretinal wound healing. Four days, two weeks, and two months after surgery, the control eyes still had not developed chorioretinal wound healing. In contrast, the edges of the retinal tear treated with TGF-beta were adherent to the underlying Bruch's membrane via localized fibrous tissue without apparent effects elsewhere. These results demonstrate intraocular in vivo bioactivity of TGF-beta and suggest that TGF-beta may have a potential role as an alternative means for inducing a chorioretinal adhesion in the treatment of retinal tears.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Smad7 Gene Overexpression on Transforming Growth Factor beta-Induced Retinal Pigment Fibrosis in a Proliferative Vitreoretinopathy Mouse Model
Saika et al.
Arch Ophthalmol 2007;125:647-654.
ABSTRACT | FULL TEXT  

In vivo and in vitro feasibility studies of intraocular use of seprafilm to close retinal breaks in bovine and rabbit eyes.
Sueda et al.
IOVS 2006;47:1142-1148.
ABSTRACT | FULL TEXT  

Transforming Growth Factor-{beta}1, -{beta}2, and -{beta}3 In Vivo: Effects on Normal and Mitomycin C-Modulated Conjunctival Scarring
Cordeiro et al.
IOVS 1999;40:1975-1982.
ABSTRACT | FULL TEXT  

Macular holes---a diagnostic and therapeutic enigma?
KAMPIK
Br. J. Ophthalmol. 1998;82:338-338.
FULL TEXT  

Fundus autofluorescence in patients with macular holes imaged with a laser scanning ophthalmoscope
von Rückmann et al.
Br. J. Ophthalmol. 1998;82:346-351.
ABSTRACT | FULL TEXT  

Surgical management of macular holes: results using gas tamponade alone, or in combination with autologous platelet concentrate, or transforming growth factor beta 2
Minihan et al.
Br. J. Ophthalmol. 1997;81:1073-1079.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.